证券之星消息，8月18日食品加工板块较上一交易日上涨0.55%，*ST春天领涨。当日上证指数报收于 3728.03，上涨0.85%。深证成指报收于11835.57，上涨1.73%。食品加工板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 600381 | *ST春天 | 4.41 | 5.00% | 6.66万 | 2913.05万 | | | 600530 | 交大昂立 | 60'8 | 3.85% | 18.56万 | 1.48亿 | | | 002626 | 全达威 | 19.65 | 3.37% | 20.87万 | | 4.09亿 | | 836826 | 盖世食品 | 12.50 | 2.88% | - 4.46万 | 5546.05万 | | | 605089 | 味知香 | 26.30 | 2.81% | 1.69万 | 4377.88万 | | | 002216 | 三全食品 | 11.43 | 2.14% | 12.60万 | | 1.43 ...

Market Overview - On August 15, the food processing sector rose by 0.84%, led by *ST Chuntian [1] - The Shanghai Composite Index closed at 3696.77, up 0.83%, while the Shenzhen Component Index closed at 11634.67, up 1.6% [1] Stock Performance - The top-performing stocks in the food processing sector included: - *ST Chuntian: Closed at 4.20, up 2.19% with a trading volume of 83,500 shares and a turnover of 34.68 million yuan [1] - Jindawei: Closed at 19.01, up 1.77% with a trading volume of 67,300 shares and a turnover of 127 million yuan [1] - Jiyuan Group: Closed at 30.32, up 1.27% with a trading volume of 30,900 shares and a turnover of 93.08 million yuan [1] - Other notable stocks included: - Xianle Health: Closed at 23.22, up 1.26% [1] - Kangbiter: Closed at 21.81, up 1.25% [1] Capital Flow - The food processing sector saw a net inflow of 51.53 million yuan from institutional investors, while retail investors experienced a net outflow of 91.07 million yuan [2] - The main capital inflows were observed in: - Shuanghui Development: Net inflow of 21.84 million yuan from institutional investors [3] - Jindawei: Net inflow of 16.96 million yuan from institutional investors [3] - Tangchen Beijian: Net inflow of 13.28 million yuan from institutional investors [3]

每经头条（nbdtoutiao）——防晒霜调查：成本3元，敢卖几十元！工厂老板：这行水太深，几倍利润算 少的 每经AI快讯，技源集团8月13日晚间发布公告称，公司第二届第四次董事会会议于2025年8月12日在公 司上海分公司会议室以现场结合通讯的方式召开。会议审议了《关于调整部分募投项目金额的议案》等 文件。 （记者 张明双） ...

格隆汇8月13日丨技源集团(603262.SH)公布，公司于2025年8月12日召开第二届董事会第四次会议、第 二届监事会第三次会议，审议通过了《关于使用募集资金向全资子公司增资及提供借款以实施募投项目 的议案》，同意公司以募集资金净额14,730.50万元、9,913.75万元一次或分次向全资子公司技源健康科 技（江苏）有限公司（简称"启东技源"）增资或借款的形式实施募集资金投资项目。 ...

Group 1 - The company plans to use a total of up to 450 million yuan of idle raised funds for cash management [1] - The usage period for the funds is set for 12 months from the date of approval by the company's board of directors [1] - The funds can be used in a rolling manner within the specified limit and time frame [1]

格隆汇8月13日丨技源集团(603262.SH)公布，公司拟使用总额不超过45,000万元（含本数）的闲置募集 资金进行现金管理，使用期限为自公司董事会审议通过之日起12个月内。在前述额度和期限范围内，资 金可循环滚动使用。 ...

经中国证券监督管理委员会《关于同意技源集团股份有限公司首次公开发行股 票注册的批复》（证监许可〔2025〕799 号）同意注册，并经上海证券交易所同意， 公司向社会公开发行人民币普通股（A 股）5,001.00 万股，发行价格为 10.88 元/股， 本次发行募集资金总额为 54,410.88 万元，扣除发行费用 6,429.06 万元（不含增值税） 后，募集资金净额为 47,981.82 万元。立信会计师事务所（特殊普通合伙）对公司本 次公开发行新股的资金到位情况进行了审验并出具了《验资报告》 （信会师报字[2025] 第 ZK10290 号）。公司已对上述募集资金进行专户存储管理，并已与保荐机构、募 集资金专户监管银行签订募集资金监管协议。 二、募集资金投资项目情况 证券代码：603262 证券简称：技源集团 公告编号：2025-003 技源集团股份有限公司 关于调整部分募投项目金额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 单位：万元 调整前拟投入 调整后拟投入 序号 项目名称 项目总投 ...

证券代码：603262 证券简称：技源集团 公告编号：2025-005 技源集团股份有限公司 关于使用募集资金置换先期已支付发行费用的 自筹资金的公告 一、募集资金基本情况 经中国证券监督管理委员会《关于同意技源集团股份有限公司首次公开发行股 票注册的批复》（证监许可〔2025〕799 号）同意注册，并经上海证券交易所同意， 公司向社会公开发行人民币普通股（A 股）5,001.00 万股，发行价格为 10.88 元/股， 本次发行募集资金总额为 54,410.88 万元，扣除发行费用 6,429.06 万元（不含增值税） 后，募集资金净额为 47,981.82 万元。立信会计师事务所（特殊普通合伙）对公司本 次公开发行新股的资金到位情况进行了审验并出具了《验资报告》 （信会师报字[2025] 第 ZK10290 号）。公司已对上述募集资金进行专户存储管理，并已与保荐机构、募 集资金专户监管银行签订募集资金监管协议。 二、募集资金投资项目情况及调整情况 根据《技源集团股份有限公司首次公开发行股票并在主板上市招股说明书》及 《技源集团股份有限公司关于调整部分募投项目金额的公告》，首次公开发行股票 所募集的资金扣除 ...

证券代码：603262 证券简称：技源集团 公告编号：2025-002 技源集团股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 技源集团股份有限公司（以下简称"公司"）第二届监事会第三次会议通知和 文件于 2025 年 8 月 8 日以电话、邮件方式送达公司全体监事，会议于 2025 年 8 月 实际出席监事 3 人。会议由监事会主席黄靓女士召集并主持。本次会议的召集、召 开及表决程序符合《中华人民共和国公司法》等法律、法规、规范性文件以及《公 司章程》的有关规定。 二、监事会会议审议情况 监事会认为：公司本次对募投项目拟使用募集资金金额的调整是基于募集资金 净额低于原计划投入募投项目中募集资金金额的实际情况，并为保证募投项目的顺 利实施和募集资金的高效使用所做出的决策。本次调整不会对募集资金的正常使用 造成实质性影响，不存在改变或变相改变募集资金用途和损害股东利益的情况。本 次调整符合中国证监会、上海证券交易所关于上市公司募集资金管理的有关规定， 有利于提高公司资金使用效率，优化资 ...

Core Viewpoint - The company has approved the use of raised funds to increase capital and provide loans to its wholly-owned subsidiary, Qidong Jiyuan, for the implementation of fundraising investment projects [1][7]. Fundraising Overview - The company raised a total of RMB 54,410.88 million from the public offering of 50.01 million shares at a price of RMB 10.88 per share, with a net amount of RMB 47,981.82 million after deducting issuance costs of RMB 6,429.06 million [1][2]. Fundraising Investment Projects - The funds will be allocated to the following projects: - Jiyuan Group Nutrition Health Raw Material Production Base Construction Project - Qidong Jiyuan Nutrition Health Food Production Line Expansion Project - The total investment for these projects is RMB 60,272.93 million, with the adjusted amount for fundraising being RMB 47,981.82 million [3][2]. Capital Increase or Loan Details - The company plans to use RMB 14,730.50 million and RMB 9,913.75 million for capital increase or loans to Qidong Jiyuan, which will be used exclusively for the aforementioned projects [3][7]. - The loan terms will be based on the actual needs of the projects, with repayment options available [3][6]. Subsidiary Information - Qidong Jiyuan is a wholly-owned subsidiary of the company, with a registered capital of RMB 21,264.774 million and a business scope that includes health food production and sales [4][5]. Financial Performance of Subsidiary - Recent financial data for Qidong Jiyuan shows: - Total assets: RMB 34,498.41 million (audited), RMB 35,114.03 million (unaudited) - Total liabilities: RMB 5,637.25 million (audited), RMB 5,445.63 million (unaudited) - Net assets: RMB 28,861.16 million (audited), RMB 29,668.41 million (unaudited) - Revenue: RMB 24,033.00 million (audited), RMB 5,883.90 million (unaudited) - Net profit: RMB 3,277.50 million (audited), RMB 807.24 million (unaudited) [6]. Impact on the Company - The use of raised funds for the subsidiary is aligned with the company's long-term planning and development strategy, ensuring the smooth implementation of the fundraising investment projects [5][7]. - The company maintains control over the subsidiary's operations during the loan period, which mitigates financial risks [5][6]. Fund Management - The raised funds will be managed in a dedicated account, with a four-party supervision agreement established to ensure compliance with relevant regulations and proper use of funds [6][7]. Review Procedures - The board of directors and the supervisory board have approved the use of funds for the capital increase or loans, confirming adherence to necessary approval processes and regulations [7][8].